- Home
- JEQ vs LUCD Comparison
JEQ vs LUCD Comparison
Compare JEQ & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JEQ
- LUCD
- Stock Information
- Founded
- JEQ 1990
- LUCD 2018
- Country
- JEQ United States
- LUCD United States
- Employees
- JEQ N/A
- LUCD N/A
- Industry
- JEQ Air Freight/Delivery Services
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- JEQ Consumer Discretionary
- LUCD Health Care
- Exchange
- JEQ Nasdaq
- LUCD Nasdaq
- Market Cap
- JEQ 99.8M
- LUCD 105.0M
- IPO Year
- JEQ N/A
- LUCD 2021
- Fundamental
- Price
- JEQ $8.23
- LUCD $1.10
- Analyst Decision
- JEQ
- LUCD Strong Buy
- Analyst Count
- JEQ 0
- LUCD 4
- Target Price
- JEQ N/A
- LUCD $3.94
- AVG Volume (30 Days)
- JEQ 32.0K
- LUCD 720.7K
- Earning Date
- JEQ 01-01-0001
- LUCD 08-13-2025
- Dividend Yield
- JEQ 7.05%
- LUCD N/A
- EPS Growth
- JEQ N/A
- LUCD N/A
- EPS
- JEQ N/A
- LUCD N/A
- Revenue
- JEQ N/A
- LUCD $4,360,000.00
- Revenue This Year
- JEQ N/A
- LUCD $22.80
- Revenue Next Year
- JEQ N/A
- LUCD $221.19
- P/E Ratio
- JEQ N/A
- LUCD N/A
- Revenue Growth
- JEQ N/A
- LUCD 14.74
- 52 Week Low
- JEQ $4.99
- LUCD $0.73
- 52 Week High
- JEQ $6.39
- LUCD $1.80
- Technical
- Relative Strength Index (RSI)
- JEQ 68.63
- LUCD 58.59
- Support Level
- JEQ $7.95
- LUCD $0.98
- Resistance Level
- JEQ $8.29
- LUCD $1.06
- Average True Range (ATR)
- JEQ 0.11
- LUCD 0.06
- MACD
- JEQ 0.01
- LUCD 0.02
- Stochastic Oscillator
- JEQ 90.15
- LUCD 100.00
About JEQ abrdn Japan Equity Fund Inc.
Aberdeen Japan Equity Fund Inc is a United States-based closed-end diversified management investment company. Its investment objective is to outperform over the long term, on a total return basis (including appreciation and dividends), the Tokyo Stock Price Index ("TOPIX"). The fund seeks to achieve its investment objective by investing a majority of its assets, in equity securities of companies listed on the Tokyo Stock Exchange or listed on the over-the-counter market in Japan or listed on other stock exchanges in Japan. The portfolio of investments is spread across Consumer Discretionary, Industrials, Information Technology, Financials, and other sectors.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.